论文部分内容阅读
1 资料与方法 1.1 病例选择:121例均为门诊患者,根据其临床表现,按《中国腹泻病诊断治疗方案》制定的标准确诊为小儿腹泻。治疗组61例:男31例,女30例;年龄为2月～4岁。思密达组60例:男34例,女26例,年龄2月～4岁。两组的性别、年龄、病程及病情轻重均相仿,具有可比性。 1.2 治疗方法:治疗组应用复方APC碳(APC 6g,烧成炭,食母生6g,维生素B_12g,复方苯乙哌啶2.4g,病毒灵1.5g共研末,混匀分装15包),2月～1岁半包/次,2～4岁1包/次,每日3次,对照组用国产思密达,剂量为<1岁3g/d,2～4岁3～6g/d,口服。两组用药天数均为3～5天。 1.3 疗效评价及结果:显效:症状、体征、实验室检查均恢复正常;有效:服药72h大便次数减至2次/d,大便性状好转,水份明显减少;无效:服药72h后,大便次数、性状无明显好
1 Materials and Methods 1.1 Case Selection: 121 cases were outpatients, according to their clinical manifestations, according to “Chinese diarrhea diagnosis and treatment programs,” developed standards for the diagnosis of pediatric diarrhea. Treatment group of 61 patients: 31 males and 30 females; aged 2 months to 4 years. Smectite group of 60 patients: 34 males and 26 females, aged 2 months to 4 years. Two groups of gender, age, duration and severity of illness are similar, comparable. 1.2 Treatment: The treatment group application of compound APC carbon (APC 6g, charcoal, food mother 6g, vitamin B_12g, compound diphenoxylate 2.4g, viral spirit 1.5g total research at the end, mixing and packaging 15 packets) 2 months to 1 year old half pack / time, 2 to 4 years old 1 pack / times, 3 times a day, the control group with domestic Smecta, the dose of <1 year old 3g / d, 2 to 4 years old 3 ~ 6g / d ,oral. Two groups of drug days are 3 to 5 days. 1.3 Efficacy evaluation and results: markedly effective: symptoms, signs, laboratory tests returned to normal; effective: stool 72h reduced to 2 times / d, stool traits improved, water decreased significantly; invalid: 72h after taking stool frequency, No obvious traits